Concepedia

Matthew Siegel

MS

Statistics

Publications

21

Citations

2.2K

H-Index

19

Active since

1981

Affiliations

Stanford University(Current)

Ardelyx (United States)

Neurological Surgery

Washington University in St. Louis

University of Oslo

Matthew Siegel is an author at Stanford University specializing in life sciences, pharmacology, and celiac disease.

Publications per year

1981–2024

21

Publications

21

Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Patients With Celiac Sprue

Jonathan Gass, Michael T. Bethune, Matthew Siegel et al. · Gastroenterology · 2007 · 236 citations · Full text

, , +14

Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury

Matthew Siegel, Pavel Strnad, Richard E. Watts et al. · PLoS ONE · 2008 · 202 citations · Full text

, , +17

Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform

Kenji Kozuka, Ying He, Samantha Koo-McCoy et al. · Stem Cell Reports · 2017 · 181 citations · Full text

, , +17

Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy

Matthew Siegel, Kihang Choi, Chaitan Khosla et al. · Oncogene · 2006 · 171 citations

, , +15

Chemistry and Biology of Dihydroisoxazole Derivatives: Selective Inhibitors of Human Transglutaminase 2

Kihang Choi, Matthew Siegel, Justin L. Piper et al. · Chemistry & Biology · 2005 · 165 citations · Full text

, , +7

1–5 of 21